China Automotive Systems' Fully Redundant AP04 EPS Platform Meets ASPICE 4.0 CL2 in Joint Assessment by European OEM and UL WUHAN, China, Oct. 5, 2026 /PRNewswire/ — China Automotive Systems, Inc. (NASDAQ:… CISION PRNewswireOctober 5, 2026
OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®, now commercially available in the U.S. OMLYCLO® (omalizumab-igec) is the first and onlyFDA-approved omalizumab biosimilar approved for all four… CISION PRNewswireOctober 5, 2026
Press ReleaseBitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.02 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $17.4 Billion Bitmine owns 4.9% of the total ETH coin supply of 122.1 million… CISION PRNewswireOctober 5, 2026
Press ReleaseMICROIP and AQLS Draw Defense, Healthcare and Energy Demand for NDAA-Compliant AI Drones at Taiwan Expo USA DALLAS, Oct. 5, 2026 /PRNewswire/ — MICROIP Inc. (TPEx: 7796) and its… CISION PRNewswireOctober 5, 2026
Habitat for Humanity's new global research report finds three in four people are cutting back on essentials to afford housing ATLANTA, Oct. 5, 2026 /PRNewswire/ — Housing costs are forcing millions of… CISION PRNewswireOctober 5, 2026
Press ReleaseManulife Announces Presenting Partnership of The Hinton Lectures™ on AI Safety C$ unless otherwise stated … CISION PRNewswireOctober 5, 2026
ECARX Completes Acquisition of Flyme Software Business, Securing End-to-End Operating System Capabilities Completion brings Flyme Auto and Flyme OS fully in-house, aligning ECARX’s hardware… CISION PRNewswireOctober 5, 2026
Ajinomoto Bio-Pharma Services Unveils Refreshed Global Brand, Showcasing its Strength in Specialization Reflects the depth of expertise and innovation Aji Bio-Pharma brings to customers… CISION PRNewswireOctober 5, 2026
